Dr. Sarah Moyon obtained her B.Sc. in cellular and molecular biology (2006) from Université Diderot Paris 7 (France) and her M.Sc. in cellular and molecular biology, speciality neurosciences (2008) from Université UPMC Paris 6 and École Normale Supérieure Ulm (France). She completed her Ph.D. at the Université UPMC Paris 6 (2013), in the laboratory of Pr. Catherine Lubetzki (CR-ICM, Pitié Salpétrière, France), where she characterized the profile of adult oligodendroglial cells, the main myelinating cells of the central nervous system. She then joined the team of Dr. Patrizia Casaccia in 2014 for her post-doctoral training, addressing the role of DNA methylation and hydroxy-methylation on the oligodendroglial lineage, during repair and aging. She was sponsored by a National Multiple Sclerosis Society fellowship and the Fritz Krauth Paralyzed Veterans of America fellowship. She was promoted as research assistant professor in July 2019, to start her own research program on aging and oligodendroglial cell biology.
Her research combined whole genome and epigenome bioinformatic approaches with in vitro and in vivo functional experiments. Her main focus is the study of aging, especially in oligodendrocyte progenitor cells, and how it impacts learning myelin plasticity and remyelination.
remyelination mouse models, histochemistry, cell culture, behavioral assays, RNA Sequencing, ERRBS, RRHP, flow-activated cytometry.